| ¿µ¹® | Gram stain | ÇÑ±Û | ±×¶÷¿°»ö |
|---|---|---|---|
| ¼³¸í | ¹Ì»ý¹°À» ¿°»öÇÏ´Â ¹æ¹ý ÁßÀÇ Çϳª. 1884³â µ§¸¶Å©ÀÇ ÀÇ»ç H.C.J. ±×¶÷(1853~ 1938)ÀÌ °í¾ÈÇÑ Æ¯¼ö ¿°»ö¹ýÀÌ´Ù. ÀÌ ¿°»ö¹ýÀ» »ç¿ëÇÏ¸é ¹Ì»ý¹°Àº ¾ç¼º±Õ°ú À½¼º±ÕÀÇ 2¹«¸®·Î Å©°Ô ³ª´¶´Ù. ¿°»ö¹ýÀº ±ÕÀ» À¯¸®¸é¿¡ ¹Ù¸£°í °¡¿ °íÁ¤ÇÑ´Ù. Á¨½Ã¾È¹ÙÀÌ¿À·¿, Å©¸®½ºÅ» ¹ÙÀÌ¿À·¿, ¸ÞÆ¿¹ÙÀÌ¿À·¿ µî ÆÄ¶ó·ÎÁî ¾Æ´Ò¸°°è »ö¼ÒÀÇ ¾î´À Çϳª¸¦ »ç¿ëÇÏ¿© ¿ì¼± ¿°»öÇϰí ÀÌ¾î¼ ·ç°ñ¾×À» ÀÛ¿ë½ÃŲ µÚ, ¿¡Åº¿Ã ¶Ç´Â ¾Æ¼¼ÅæÀ¸·Î Å»»öÇÑ´Ù. À̶§ Å»»öµÇÁö ¾Ê°í º¸¶ó»öÀ» Ÿ³ª³»´Â °ÍÀ» ±×¶÷¾ç¼º±ÕÀ̶ó ºÎ¸£¸ç, Æ÷µµ¾Ë±Õ-Æó·Å¾Ë±Õ-»ç½½¾Ë±Õ µîÀÌ ´ëÇ¥ÀûÀÎ ¿¹ÀÌ´Ù. Å»»öµÇ¸é ±×¶÷À½¼º±ÕÀ̶ó ºÎ¸£¸ç, ´ëÀå±Õ-³ì³ó±Õ µîÀÌ ÀÖ´Ù. ÃÖÈÄ¿¡ »çÇÁ¶ó´Ñ, Ç«½Å µî Àû»ö°èÀÇ »ö¼Ò¾×À¸·Î ÈÄ¿°»öÀ» ÇÑ´Ù. ¹Ì»ý¹°ÀÇ °¨º°¿¡ Áß¿äÇÑ ¿°»ö¹ýÀÌ¸ç ¿°»ö¼ºÀÇ Â÷ÀÌ´Â ¿µ¾ç¿ä±¸¼º, ÈÇпä¹ýÁ¦(Ç×»ý¹°Áú µî)¿¡ ´ëÇÑ °¨¼ö¼ºÀÇ Â÷À̿͵µ °ü·ÃµÇ´Â Á¡ÀÌ ¸¹À¸¹Ç·Î »ç¿ë¾àÁ¦ÀÇ ¼±Åýÿ¡µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. ±×¶÷¾ç¼º±Õ°ú À½¼º±ÕÀÇ Â÷ÀÌ´Â ¼¼±Õº®ÀÇ ±¸Á¶¿¡ Àִµ¥, ¾ç¼º±ÕÀº ¼¼Æ÷¸·ÀÇ ¹Ù±ùÂÊ ÆéƼµå±Û¸®ÄÀ̶ó´Â ´ç´Ü¹éÁúÃþÀÇ µÎ²²°¡ 20~80nm³ª µÇ°í, ±×·¥À½¼º±ÕÀÇ ÆéƼµå±Û¸®Ä ÃþÀº 2~3nm·Î ¾ã°í, ´Ù½Ã ¹Ù±ùÂÊ¿¡ ¿Ü¸·À̶ó ºÎ¸£´Â ÃþÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | deoxyribonucleic acid (DNA) | ÇÑ±Û | µ¥¿Á½Ã¸®º¸ÇÙ»ê |
|---|---|---|---|
| ¼³¸í | ÇÙ»êÀÇ ÀÏÁ¾À¸·Î DNA¶ó°íµµ ÇÑ´Ù. DeoxyribonucleotideÀÇ ÁßÇÕüÀ̸ç À¯ÀüÀÚÀÇ ÈÇÐÀû º»Ã¼ÀÌ´Ù. RNA¹ÙÀÌ·¯½º ÀÌ¿ÜÀÇ ¸ðµç »ý¹°Àº DNA¸¦ À¯ÀüÀÚ·Î Áö´Ï°í ÀÖ´Ù. µð¿Á½Ã¸®º¸´ºÅ¬·¹¿ÀƼµå(deoxyribonucleotide)´Â ¿°±â¿Í ´ç(2'-deoxy-D-ribose)°ú ÀλêÀ¸·Î ÀÌ·ç¾îÁø´Ù. ¿°±â´Â ¾Æµ¥´Ñ(adenine), ±¸¾Æ´Ñ(guanine), Ƽ¹Î(thymine)¹× ½ÃÅä½Å(cytosine)ÀÇ 4°¡ÁöÀ̸ç, À̰ÍÀº ´ç¿¡ ºÎÂøµÇ¾î ÀÖ´Ù. ÀÎ»ê ¿ª½Ã ´çÀÇ ÇÑ ºÎºÐ¿¡ ºÎÂøµÇ¾î ÀÖ´Ù. ÀÌ deoxyribonucleotideÀÇ ´çÀº ´Ù¸¥ deoxy- ribonucleotideÀÇ ´ç°ú ÀλêÀ» »çÀÌ¿¡ ³õ°í °áÇÕÀ» ÇÏ°Ô µÇ¾î ÇϳªÀÇ ±ä »ç½½À» Çü¼ºÇÏ°Ô µÈ´Ù. Áï ´ç°ú ÀλêÀÌ ÁÖÃàÀÌ µÇ¾î¼ deoxyribonucleotideÀÇ ±ä »ç½½À» ¸¸µç´Ù. ÀÌ deoxyribonucleotideÀÇ »ç½½ µÎ °³´Â °¢°¢ deoxyribonucleotide¿¡ ºÎÂøµÇ¾î ÀÖ´Â ¿°±âµéÀÌ °áÇÕÀ» ÇÏ¿© µÎ °³ÀÇ »ç½½ÀÌ °áÇյǾî ÀÖ´Â ÀÌÁß³ª¼± ±¸Á¶¸¦ ¸¸µé°Ô µÈ´Ù. 4°¡Áö ¿°±â ¾Æµ¥´ÑÀº Ƽ¹Î°ú °áÇÕÀ» Çϰí, ½ÃÅä½Å°ú °áÇÕÀ» ÇÏ°Ô µÈ´Ù. Áï ´ç°ú ÀλêÀº ±ä »ç½½À» ¸¸µå´Â ¿ªÇÒÀ» ÇÏ°í ±ä »ç½½¿¡ ºÎÂøµÈ ¿°±âµéÀÇ °áÇÕ¿¡ ÀÇÇØ¼ µÎ °³ÀÇ ±ä »ç½½Àº ¼·Î ºÙ¾î¼ ÀÌÁß³ª¼± ±¸Á¶¸¦ ¸¸µç´Ù. DNAÀÇ À¯ÀüÁ¤º¸´Â ¿°±â¿¡ ÀúÀåµÈ´Ù. 4°³ÀÇ ¿°±âÀÇ Á¶ÇÕ°ú ¹è¿ÀÌ À¯ÀüÁ¤º¸¸¦ º¸°üÇÏ´Â ÇϳªÀÇ ¾ÏÈ£ ¿ªÇÒÀ» ÇàÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | retinoic acid | ÇÑ±Û | ·¹Æ¼³ë»ê |
|---|---|---|---|
| ¼³¸í | C20H28O2. ºñŸ¹Î AÀÇ ¾ËÄڿñ⸦ ¾Ëµ¥È÷µå·Î »êÈÇÑ ÈÄ ´Ù½Ã Ä«¸£º¹½Ç»êÀ¸·Î »êÈÇÏ¿© ¾òÀº »ê. ¹ß»ýÁßÀÇ ¼¼Æ÷¿¡ ÀÛ¿ëÇÏ¿© ÇüŸ¦ ¸¸µå´Âµ¥ °ü¿©ÇÑ´Ù. |
||
| ¿µ¹® | ribonucleic acid | ÇÑ±Û | ¸®º¸ÇÙ»ê |
|---|---|---|---|
| ¼³¸í | Ribonucleotide monomer·Î ÀÌ·ç¾îÁø ÇÙ»êÀ¸·Î ¿°±â, ´ç, ÀλêÀ¸·Î ±¸¼ºµÈ´Ù. ¿°±â´Â adenine, guanine, cytosine, uracilÀÇ 4Á¾·ù°¡ ÀÖÀ¸¸ç, ´çÀº 5ź´çÀÌ´Ù. RNA´Â DNA¸¦ ÁÖÇüÀ¸·Î ÇÏ¿© »óº¸ÀûÀ¸·Î °áÇÕ, Çü¼ºµÇ¸ç ´Ü¹éÁúÀ» ¸¸µé¾î³»´Â µ¥¿¡ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. Àü·É RNA(mRNA)´Â ´Ü¹éÁú ÇÕ¼º¿¡ ÀÖ¾î °¡Àå ±âº»ÀÌ µÇ´Â DNAÀÇ ¼¿À» »óº¸ÀûÀ¸·Î ¿Å°Ü ¹Þ¾Æ Àü´ÞÇÏ´Â Àü·É±¸½ÇÀ» ÇÏ´Â RNA. ¸®º¸¼Ø RNA(rRNA) ¸®º¸¼ØÀ» Çü¼ºÇÏ´Â 4°¡Áö RNA»ç½½(28S, 18S, 5.8S, 5S·Î ±¸¼º). Àü´Þ RNA(tRNA) ƯÁ¤ ¾Æ¹Ì³ë»êÀ» ÇÑÂÊ ³¡¿¡ Áö´Ï°í »óº¸Àû ¼¿ÀÇ mRNA¿Í ÀϽÃÀû °áÇÕÀ» ÀÌ·ç¸ç ´Ü¹éÁú ÇÕ¼º¿¡ Á÷Á¢ ±â¿©ÇÏ´Â RNAÀÌ´Ù. |
||
| ¿µ¹® | acid | ÇÑ±Û | »ê |
|---|---|---|---|
| ¼³¸í | ¹°¿¡ ³ì¾ÒÀ» ¶§ ÀÌ¿ÂÈÇÏ¿© ¼ö¼Ò ÀÌ¿ÂÀ» ¸¸µå´Â ¹°Áú. ½Å¸ÀÀÌ ³ª°í û»ö ¸®Æ®¸Ó½º Á¾À̸¦ ºÓ°Ô º¯È½ÃŰ¸ç ¿°±â¿ÍÀÇ ÁßÈ ¹ÝÀÀ¿¡ ÀÇÇÏ¿© ¹°°ú ¿°À» ¸¸µé°í ÀÌ¿ÂÈ ¿¿¡¼ ¼ö¼Òº¸´Ù ¾Õ¿¡ ÀÖ´Â ±Ý¼Ó°ú ¹ÝÀÀÇÏ¿© ¿°À» ¸¸µé¸é¼ ¼ö¼Ò¸¦ ¹ß»ý½ÃŲ´Ù. ¼ö¼Ò ¿øÀÚ¸¦ ÀÌ¿ÂÈÇÏ´Â ÈûÀÇ °¾à¿¡ µû¶ó °»ê°ú ¾à»êÀ¸·Î ³ª´¶´Ù. |
||
| HE stain | Hematoxylin-Eosin stain |
|---|---|
| AFB Stain | Acid Fast Bacilli Stain |
| H and E | hematoxylin and eosin [stain] |
| HE | half-scan with extrapolation; hard exudate; hektoen enteric [agar]; hemagglutinating encephalomyelit... |
| H&E | hematoxylin and eosin [stain]; hemorrhage and exudate; heredity and environment |
| PTAH | Phosphotungstic acid hematoxylin |
|---|---|
| PWS | Port Wine Stain |
| H&E | Hematoxylin & Eosin |
| EA | Ehrlich Ascites |
| EAC | Ehrlich Ascites Carcinoma |
| Ehrlich's acid haematoxylin stain | <technique> An alum type of haematoxylin stain used as a regressive staining method for nuclei, followed by differentiation to required staining intensity; the solution may be allowed to ripen naturally in sunlight or partially oxidised with sodium iodate. (05 Mar 2000) |
|---|---|
| hematoxylin | <chemical> Basophilic stain that gives a blue colour (to the nucleus of a cell for example), commonly used in conjunction with eosin that stains the cytoplasm pink or red. Various modifications of haematoxylin have been developed. The histopathologist's H&E is haematoxylin and eosin. (18 Nov 1997) |
| Ehrlich's aniline crystal violet stain | <technique> A stain for Gram-positive bacteria. (05 Mar 2000) |
| Ehrlich's triacid stain | <technique> A differential leukocytic stain comprised of saturated solutions of orange G, acid fuchsin, and methyl green. (05 Mar 2000) |
| Ehrlich's triple stain | <technique> A mixture of indulin, eosin Y, and aurantia. (05 Mar 2000) |
| Rambourg's chromic acid-phosphotungstic acid stain | <technique> A stain for glycoproteins, used with an electron microscope, with which ultrathin tissue sections reveal complex carbohydrates in the same locations as shown by Rambourg's periodic acid-chromic methenamine-silver stain. (05 Mar 2000) |
| carcinoma, ehrlich tumour | A transplantable, poorly differentiated malignant tumour which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. (12 Dec 1998) |
| Paul Ehrlich | <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology. Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series. In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background. Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units). at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced. Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy. In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915. Lived: 1854-1915. (18 Nov 1997) |
| Heinz-Ehrlich body | A round oxyphil body found in the red blood cell in case of haemocytolysis due to a specific blood poison. Synonym: Heinz-Ehrlich body. (05 Mar 2000) |
| Ehrlich | Paul, German bacteriologist, immunologist, and Nobel laureate, 1854-1915. See: Ehrlichia, Ehrlich's anaemia, Ehrlich's inner body, Ehrlich's phenomenon, Ehrlich's postulate, Ehrlich's diazo reagent, Ehrlich's theory, Ehrlich-Turk line. See entries under stain; reaction. (05 Mar 2000) |
| Ehrlich, Paul | <person> A brilliant scientist and student, born in Silesia, Germany, who at the age of 23 published his first scientific paper which was on the discovery of the mast cells - a name coined by him (1887). While a resident in medicine at Charite Hospital in Berlin he utilised the newly discovered aniline dyes to develop some of the basic methods of histology. Among his contributions are: The preparation and staining of blood smears, he demonstrated granules in leukocytes, described the neutrophil, basophil, eosinophil, myelocyte, and mononuclear cells (white blood cells), he demonstrated normoblasts, megaloblasts and microblasts of the erythrocytic (red blood cell) series. In 1887, he differentiated lymphocytic leukaemia from "bone marrow leukaemia" (myeloid) on blood smear, in 1888, he described aplastic anaemia, in 1882 the diazo reaction of typhoid urines, in 1882, less than six weeks after Koch described the Tuberculus bacillus, Ehrlich had described its acid-fastness and devised the fuchsin stain to demonstrate the pink rod on a blue background. Ehrlich fell ill with tuberculosis and went to Egypt for 3 years for rest and cure. Following his return, he entered the field of immunology. at Von Behring's request, he developed means of standardising antitoxin dosage (immunization units). at the age of 42, he became director of the "Royal Institute for Standardisation and Investigation of Antitoxic Sera." Here he devised his famous "side-chain" theory of immunisation. It has since been replaced. Paul Ehrlich reinvestigated Bordet's alexin and heat-stable substance and named them "complement" and "immune body". Ehrlich coined the terms and created a new science of chemotherapy. In 1910 he discovered Salvarsan or 606, a therapeutic antiluetic. For his silver bullet (Salvarsan) in 1908, he received the Nobel Prize. This scientist was greatly concerned over the problem of drug fastness which still remains a problem. He died August 20, 1915. Lived: 1854-1915. (18 Nov 1997) |
| Ehrlich reaction | The reaction of the indole derivatives with aromatic aldehydes; e.g., tryptophan and p-dimethylaminobenzaldehyde in H2SO4 give a red-violet colour useful in assaying proteins for tryptophan content. Synonym: Ehrlich reaction. (05 Mar 2000) |
| Ehrlich's anaemia | <haematology> This form of anaemia occurs when the bone marrow ceases sufficient red and white blood cell production. It may be induced by exposures to high levels of toxic chemicals, radiation and certain drugs. It is generally unresponsive to specific therapy, often accompanied by granulocytopenia and thrombocytopenia, in which the bone marrow may not necessarily be hypocellular or hypoplastic but fails to produce adequate numbers of peripheral blood elements. The term actually is all inclusive and most probably encompasses several clinical syndromes. Origin: Gr. Haima = blood (29 Sep 1997) |
| Ehrlich's benzaldehyde reaction | A test for urobilinogen in the urine, by dissolving 2 g of dimethyl-p-aminobenzaldehyde in 100 ml of 5% hydrochloric acid and adding this reagent to urine; a red colour in the cold indicates the presence of an excessive amount of urobilinogen. (05 Mar 2000) |
| Ehrlich's diazo reaction | The reaction of diazotised sulfanilic acid with bilirubin to form azobilirubin, which forms the basis of quantitating the amount of bilirubin in biological fluids. See: van den Bergh's test. Synonym: Ehrlich's diazo reaction. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|